MedTrace Logo

Registry for Eosinophilic Gastrointestinal Disorders (REGID)

NCT01382563 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2020-09-02

No results posted yet for this study

Summary

Develop Registry tool

Conditions

  • Eosinophilic Gastrointestinal Disorders (EGID)
  • Eosinophilic Esophagitis
  • Eosinophilic Disorder

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Children's Hospital Medical Center, Cincinnati

    lead OTHER

Principal Investigators

  • Marc E. Rothenberg, MD, PhD · Children's Hospital Medical Center, Cincinnati

Eligibility

Min Age
1 Year
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01382563 on ClinicalTrials.gov